45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
●Min / max negotiated charges: assessment threshold met
●Free, public, no login required: assessment threshold met
Procedures listed
14,899
Insurances with rates
16
CPT / HCPCS codes
11,554
Most expensive procedures (gross)
J0225
$328,618
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$744,578
J0225
$328,618
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$744,578
J1303
$176,325
RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION
Gross
$399,514
J1303
$176,325
RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION
Gross
$399,514
90378
$129,351
PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION
Gross
$293,083
90378
$129,351
PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION
Gross
$293,083
J0285
$128,024
AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE)
Gross
$290,074
J0285
$128,024
AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE)
Gross
$290,074
C1877
$109,652
THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A
Gross
$248,448
C1877
$109,652
THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A
Gross
$248,448
C1882
$82,697
ACTICOR 7 HF-T 429523
Gross
$187,374
C1882
$82,697
ACTICOR 7 HF-T 429523
Gross
$187,374
J2020
$78,077
LINEZOLID 2 MG/ML IV SYRINGE (NEONATE)
Gross
$176,905
J2020
$78,077
LINEZOLID 2 MG/ML IV SYRINGE (NEONATE)
Gross
$176,905
C1605
$75,190
PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR
Gross
$170,364
C1605
$75,190
PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR
Gross
$170,364
C1824
$72,057
OPTIMIZER SMART IPG 10-B411-3-XX
Gross
$163,266
C1824
$72,057
OPTIMIZER SMART IPG 10-B411-3-XX
Gross
$163,266
J1747
$71,803
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$162,690
J1747
$71,803
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$162,690
C1820
$68,924
KT IMP VERCISE GEVIA GENRTR M365DB1200S0
Gross
$156,167
C1820
$68,924
KT IMP VERCISE GEVIA GENRTR M365DB1200S0
Gross
$156,167
C1826
$68,924
NEUROSTIMULATOR RECHRG 977119
Gross
$156,167
C1826
$68,924
NEUROSTIMULATOR RECHRG 977119
Gross
$156,167
J9266
$68,694
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$155,647
J9266
$68,694
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$155,647
C1767
$67,499
DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX
Gross
$152,937
C1767
$67,499
DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX
Gross
$152,937
C2624
$65,791
SYS DEL PA SENS CARDIOMEMS CM2000
Gross
$149,069
C2624
$65,791
SYS DEL PA SENS CARDIOMEMS CM2000
Gross
$149,069
J9228
$64,866
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$146,973
J9228
$64,866
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$146,973
J9359
$64,704
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$146,606
J9359
$64,704
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$146,606
J0222
$62,254
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$141,054
J0222
$62,254
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$141,054
C2616
$55,609
THERASPHERE Y-90 1-20GBQ Y90THERA
Gross
$125,998
C2616
$55,609
THERASPHERE Y-90 1-20GBQ Y90THERA
Gross
$125,998
J9229
$54,747
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$124,046
J9229
$54,747
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$124,046
77371
$50,594
HC SRS CMPL MS GAMMA KNIFE TMT
Gross
$114,636
77371
$50,594
HC SRS CMPL MS GAMMA KNIFE TMT
Gross
$114,636
J9350
$50,565
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$114,570
J9350
$50,565
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$114,570
C1822
$50,127
IPG W/KIT NIPG1500
Gross
$113,576
C1822
$50,127
IPG W/KIT NIPG1500
Gross
$113,576
L8614
$49,058
IMP COCHLEAR MODEL CI624 O P1431676
Gross
$111,154
L8614
$49,058
IMP COCHLEAR MODEL CI624 O P1431676
Gross
$111,154
C1813
$47,603
CYL AMBICOR 11MMX18CM 72401452
Gross
$107,857
C1813
$47,603
CYL AMBICOR 11MMX18CM 72401452
Gross
$107,857
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $744,578 | $328,618 | $469,084 | $670,120 | 10 |
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $744,578 | $328,618 | $476,530 | $670,120 | 10 |
| J1303 | RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION | $399,514 | $176,325 | $251,694 | $359,563 | 10 |
| J1303 | RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION | $399,514 | $176,325 | $243 | $359,563 | 28 |
| 90378 | PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION | $293,083 | $129,351 | $184,642 | $263,774 | 10 |
| 90378 | PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION | $293,083 | $129,351 | $340 | $263,774 | 28 |
| J0285 | AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE) | $290,074 | $128,024 | $182,747 | $261,067 | 10 |
| J0285 | AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE) | $290,074 | $128,024 | $49.24 | $261,067 | 10 |
| C1877 | THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A | $248,448 | $109,652 | $156,522 | $223,603 | 10 |
| C1877 | THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A | $248,448 | $109,652 | $159,006 | $223,603 | 10 |
| C1882 | ACTICOR 7 HF-T 429523 | $187,374 | $82,697 | $118,046 | $168,637 | 10 |
| C1882 | ACTICOR 7 HF-T 429523 | $187,374 | $82,697 | $119,919 | $168,637 | 10 |
| J2020 | LINEZOLID 2 MG/ML IV SYRINGE (NEONATE) | $176,905 | $78,077 | $111,450 | $159,215 | 10 |
| J2020 | LINEZOLID 2 MG/ML IV SYRINGE (NEONATE) | $176,905 | $78,077 | $5.24 | $159,215 | 10 |
| C1605 | PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR | $170,364 | $75,190 | $107,329 | $153,328 | 10 |
| C1605 | PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR | $170,364 | $75,190 | $109,033 | $153,328 | 10 |
| C1824 | OPTIMIZER SMART IPG 10-B411-3-XX | $163,266 | $72,057 | $102,857 | $146,939 | 10 |
| C1824 | OPTIMIZER SMART IPG 10-B411-3-XX | $163,266 | $72,057 | $104,490 | $146,939 | 10 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $162,690 | $71,803 | $102,495 | $146,421 | 10 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $162,690 | $71,803 | $104,122 | $146,421 | 10 |
| C1820 | KT IMP VERCISE GEVIA GENRTR M365DB1200S0 | $156,167 | $68,924 | $98,385 | $140,550 | 10 |
| C1820 | KT IMP VERCISE GEVIA GENRTR M365DB1200S0 | $156,167 | $68,924 | $99,947 | $140,550 | 10 |
| C1826 | NEUROSTIMULATOR RECHRG 977119 | $156,167 | $68,924 | $98,385 | $140,550 | 10 |
| C1826 | NEUROSTIMULATOR RECHRG 977119 | $156,167 | $68,924 | $99,947 | $140,550 | 10 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $155,647 | $68,694 | $98,058 | $140,082 | 10 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $155,647 | $68,694 | $27,015 | $140,082 | 28 |
| C1767 | DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX | $152,937 | $67,499 | $96,350 | $137,643 | 10 |
| C1767 | DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX | $152,937 | $67,499 | $97,880 | $137,643 | 10 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $149,069 | $65,791 | $93,913 | $134,162 | 10 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $149,069 | $65,791 | $95,404 | $134,162 | 10 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $146,973 | $64,866 | $92,593 | $132,275 | 10 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $146,973 | $64,866 | $177 | $132,275 | 28 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $146,606 | $64,704 | $92,362 | $131,945 | 10 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $146,606 | $64,704 | $93,828 | $131,945 | 10 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $141,054 | $62,254 | $88,864 | $126,949 | 10 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $141,054 | $62,254 | $109 | $126,949 | 28 |
| C2616 | THERASPHERE Y-90 1-20GBQ Y90THERA | $125,998 | $55,609 | $79,379 | $113,399 | 10 |
| C2616 | THERASPHERE Y-90 1-20GBQ Y90THERA | $125,998 | $55,609 | $20,377 | $113,399 | 28 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $124,046 | $54,747 | $78,149 | $111,641 | 10 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $124,046 | $54,747 | $2,619 | $111,641 | 28 |
| 77371 | HC SRS CMPL MS GAMMA KNIFE TMT | $114,636 | $50,594 | $72,221 | $103,173 | 10 |
| 77371 | HC SRS CMPL MS GAMMA KNIFE TMT | $114,636 | $50,594 | $8,909 | $103,173 | 28 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $114,570 | $50,565 | $72,179 | $103,113 | 10 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $114,570 | $50,565 | $73,325 | $103,113 | 10 |
| C1822 | IPG W/KIT NIPG1500 | $113,576 | $50,127 | $71,553 | $102,218 | 10 |
| C1822 | IPG W/KIT NIPG1500 | $113,576 | $50,127 | $72,689 | $102,218 | 10 |
| L8614 | IMP COCHLEAR MODEL CI624 O P1431676 | $111,154 | $49,058 | $70,027 | $100,039 | 10 |
| L8614 | IMP COCHLEAR MODEL CI624 O P1431676 | $111,154 | $49,058 | $71,139 | $100,039 | 10 |
| C1813 | CYL AMBICOR 11MMX18CM 72401452 | $107,857 | $47,603 | $67,950 | $97,072 | 10 |
| C1813 | CYL AMBICOR 11MMX18CM 72401452 | $107,857 | $47,603 | $69,029 | $97,072 | 10 |
Showing top 50 of 14,899 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.